Agency Forms Undergoing Paperwork Reduction Act Review, 11441-11442 [2022-04189]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
process.26 In addition, confidential
commercial or financial information,
which a submitter both customarily and
actually treats as private, may be exempt
from disclosure under exemption 4 of
the FOIA.27 28
Board of Governors of the Federal Reserve
System, February 23, 2022.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2022–04194 Filed 2–28–22; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[30Day–22–0048]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Agency for
Toxic Substances and Disease Registry
(ATSDR) has submitted the information
collection request titled ‘‘ATSDR
Exposure Investigations (EIs)’’ to the
Office of Management and Budget
(OMB) for review and approval. ATSDR
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on August 13, 2021 to obtain
comments from the public and affected
agencies. ATSDR did not receive
comments related to the previous
notice. This notice serves to allow an
additional 30 days for public and
affected agency comments.
ATSDR will accept all comments for
this proposed information collection
project. The Office of Management and
Budget is particularly interested in
comments that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
26 5
U.S.C. 552(b)(8).
U.S.C. 552(b)(4).
28 Note that the Board may disclose a summary
of the results of supervisory stress testing pursuant
to 12 CFR 225.8(h)(5)(iii) and publishes a summary
of the results of stress testing pursuant to 12 CFR
252.46(b) and 12 CFR 238.134, which includes
aggregate data. In addition, under the Board’s
regulations, covered companies must also publicly
disclose a summary of the results of stress testing.
See 12 CFR 252.58; 12 CFR 238.146. The public
disclosure requirement contained in 12 CFR 252.58
for covered BHCs and covered IHCs is separately
accounted for by the Board in the Paperwork
Reduction Act clearance for FR YY (OMB No. 7100–
0350) and the public disclosure requirement for
covered SLHCs is separately accounted for in by the
Board in the Paperwork Reduction Act clearance for
FR LL (OMB No. 7100–0380).
jspears on DSK121TN23PROD with NOTICES1
27 5
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
ATSDR Exposure Investigations (EIs)
(OMB Control No. 0923–0048, Exp. 04/
30/2022)—Extension—Agency for Toxic
Substances and Disease Registry
(ATSDR).
Background and Brief Description
The Agency for Toxic Substances and
Disease Registry (ATSDR) is requesting
a three-year extension of ‘‘ATSDR
Exposure Investigations (EIs)’’ (OMB
Control No. 0923–0048, Exp. 04/30/
2022). This generic clearance allows the
agency to conduct EIs, through methods
developed by ATSDR. After a chemical
release or suspected release into the
environment, EIs are usually requested
by officials of a state health agency,
county health departments, the
Environmental Protection Agency
(EPA), the general public, and ATSDR
staff. EI results are used by public health
professionals, environmental risk
managers, and other decision makers to
determine if current conditions warrant
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
11441
intervention strategies to minimize or
eliminate human exposure.
During the past three years, no EIs
were completed. Instead, the ATSDR
Office of Community Health and Hazard
Assessment (OCHHA), using EI
methods, completed eight Per- or
Polyfluoroalkyl Substances Exposure
Assessments (PFAS EAs) (OMB Control
No. 0923–0059, Exp. 06/30/2022) at
communities near U.S. military
installations that used Aqueous Film
Forming Foam (AFFF). The PFAS from
the AFFF entered groundwater and
impacted the drinking water in the
nearby communities. In 2022, however,
ATSDR is conducting a follow-up EI
under this generic clearance ICR to
supplement the PFAS EAs. This EI
generic information collection (GenIC)
will evaluate additional non-drinking
water sources of environmental PFAS
exposure in two of the former EA
communities.
The general EI methods are further
described below. All of ATSDR’s
targeted biological assessments (e.g.,
urine, blood) and some of the
environmental investigations (e.g., air,
water, soil, or food sampling) involve
participants to determine whether they
are or have been exposed to unusual
levels of pollutants at specific locations
(e.g., where people live, spend leisure
time, or anywhere they might come into
contact with contaminants under
investigation).
Questionnaires, appropriate to the
specific contaminant, are generally
needed in about half of the EIs (at most,
approximately 12 per year) to assist in
interpreting the biological or
environmental sampling results. ATSDR
collects contact information (e.g., name,
address, phone number) to provide the
participant with their individual results.
ATSDR also collects information on
other possible confounding sources of
chemical(s) exposure such as medicines
taken, foods eaten, hobbies, jobs, etc. In
addition, ATSDR asks questions on
recreational or occupational activities
that could increase a participant’s
exposure potential. That information
represents an individual’s exposure
history.
The number of questions can vary
depending on the number of chemicals
being investigated, the route of exposure
(e.g., breathing, eating, touching), and
number of other sources of the
chemical(s) (e.g., products used, jobs).
We use approximately 12–20 questions
about the pertinent environmental
exposures per investigation. Typically,
the number of participants in an
individual EI ranges from 10 to 100.
Participation is completely voluntary,
and there are no costs to participants
E:\FR\FM\01MRN1.SGM
01MRN1
11442
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
other than their time. Based on a
maximum of 12 EIs per year and 100
participants each, the total estimated
annualized burden hours are 600.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Exposure Investigation Participants ................
Chemical Exposure Questions .......................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–04189 Filed 2–28–22; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Birth Defects Study To Evaluate
Pregnancy exposureS (BD–STEPS). Data
from BD–STEPS will play an important
part in the decision-making process that
determines federal research agendas,
birth defect prevention activities, and
the direction of funding programs such
as cooperative agreements.
DATES: CDC must receive written
comments on or before May 2, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0030 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
SUMMARY:
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
[60Day–22–0010; Docket No. CDC–2022–
0030]
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Type of respondents
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1,200
1
Average
burden
per response
(in hours)
30/60
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Birth Defects Study to Evaluate
Pregnancy exposureS (BD–STEPS)
(OMB Control No. 0920–0010, Exp. 2/
28/2023)—Extension—National Center
on Birth Defects and Developmental
Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Birth defects are associated with
substantial morbidity and mortality in
the United States. About one in every 33
babies is born with a birth defect. Birth
defects contributed to more than one
million hospital stays in the U.S. in
2013, resulting in $22.9 billion in
hospital costs. Birth defects are the
leading cause of infant mortality and the
fifth leading cause of loss of potential
years of life before age 65. One in five
infant deaths is due to birth defects.
For most birth defects, the causes are
not known, making prevention efforts
challenging to develop. However, to
date, primary preventive measures are
available for only a few birth defects.
For example, vaccination programs have
reduced the incidence of congenital
rubella syndrome, Rh hemolytic disease
of the newborn can be prevented by
appropriate medical practices, and
genetic counseling can provide parents
with information about the increased
risk of Down syndrome associated with
advanced maternal age. Perhaps most
importantly, folic acid intake before and
during pregnancy can prevent many
cases of fatal or permanently disabling
neural tube defects such as anencephaly
and spina bifida.
This continued burden justifies
reasonable attempts to reduce the
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Pages 11441-11442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04189]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[30Day-22-0048]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Agency
for Toxic Substances and Disease Registry (ATSDR) has submitted the
information collection request titled ``ATSDR Exposure Investigations
(EIs)'' to the Office of Management and Budget (OMB) for review and
approval. ATSDR previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on August 13,
2021 to obtain comments from the public and affected agencies. ATSDR
did not receive comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
ATSDR will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
ATSDR Exposure Investigations (EIs) (OMB Control No. 0923-0048,
Exp. 04/30/2022)--Extension--Agency for Toxic Substances and Disease
Registry (ATSDR).
Background and Brief Description
The Agency for Toxic Substances and Disease Registry (ATSDR) is
requesting a three-year extension of ``ATSDR Exposure Investigations
(EIs)'' (OMB Control No. 0923-0048, Exp. 04/30/2022). This generic
clearance allows the agency to conduct EIs, through methods developed
by ATSDR. After a chemical release or suspected release into the
environment, EIs are usually requested by officials of a state health
agency, county health departments, the Environmental Protection Agency
(EPA), the general public, and ATSDR staff. EI results are used by
public health professionals, environmental risk managers, and other
decision makers to determine if current conditions warrant intervention
strategies to minimize or eliminate human exposure.
During the past three years, no EIs were completed. Instead, the
ATSDR Office of Community Health and Hazard Assessment (OCHHA), using
EI methods, completed eight Per- or Polyfluoroalkyl Substances Exposure
Assessments (PFAS EAs) (OMB Control No. 0923-0059, Exp. 06/30/2022) at
communities near U.S. military installations that used Aqueous Film
Forming Foam (AFFF). The PFAS from the AFFF entered groundwater and
impacted the drinking water in the nearby communities. In 2022,
however, ATSDR is conducting a follow-up EI under this generic
clearance ICR to supplement the PFAS EAs. This EI generic information
collection (GenIC) will evaluate additional non-drinking water sources
of environmental PFAS exposure in two of the former EA communities.
The general EI methods are further described below. All of ATSDR's
targeted biological assessments (e.g., urine, blood) and some of the
environmental investigations (e.g., air, water, soil, or food sampling)
involve participants to determine whether they are or have been exposed
to unusual levels of pollutants at specific locations (e.g., where
people live, spend leisure time, or anywhere they might come into
contact with contaminants under investigation).
Questionnaires, appropriate to the specific contaminant, are
generally needed in about half of the EIs (at most, approximately 12
per year) to assist in interpreting the biological or environmental
sampling results. ATSDR collects contact information (e.g., name,
address, phone number) to provide the participant with their individual
results. ATSDR also collects information on other possible confounding
sources of chemical(s) exposure such as medicines taken, foods eaten,
hobbies, jobs, etc. In addition, ATSDR asks questions on recreational
or occupational activities that could increase a participant's exposure
potential. That information represents an individual's exposure
history.
The number of questions can vary depending on the number of
chemicals being investigated, the route of exposure (e.g., breathing,
eating, touching), and number of other sources of the chemical(s)
(e.g., products used, jobs). We use approximately 12-20 questions about
the pertinent environmental exposures per investigation. Typically, the
number of participants in an individual EI ranges from 10 to 100.
Participation is completely voluntary, and there are no costs to
participants
[[Page 11442]]
other than their time. Based on a maximum of 12 EIs per year and 100
participants each, the total estimated annualized burden hours are 600.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Exposure Investigation Participants... Chemical Exposure 1,200 1 30/60
Questions.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-04189 Filed 2-28-22; 8:45 am]
BILLING CODE 4163-70-P
